Company Filing History:
Years Active: 2012
Title: John Kerner: Innovator in Cancer Treatment
Introduction
John Kerner is a notable inventor based in San Francisco, CA, who has made significant contributions to the field of cancer treatment. He is affiliated with the University of California, where he focuses on innovative methods to combat breast cancer.
Latest Patents
Kerner holds a patent for "Tyrosine kinase receptor antagonists and methods of treatment for breast cancer." This patent describes a method of treatment that involves bringing cancer cells into contact with a formulation containing an inhibitor of tyrosine kinase receptors. The formulation may include an injectable carrier and two or more inhibitors, such as nordihydroguaiarectic acid (NDGA) and doxorubicin. This innovative approach aims to enhance the effectiveness of cancer therapies.
Career Highlights
Throughout his career, John Kerner has demonstrated a commitment to advancing medical science. His work has led to the development of new treatment methodologies that have the potential to improve patient outcomes in breast cancer therapy. With a focus on research and innovation, he continues to contribute to the scientific community.
Collaborations
Kerner has collaborated with esteemed colleagues, including Ira D Goldfine and Betty A Maddux. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of cancer research.
Conclusion
John Kerner's contributions to cancer treatment through his innovative patent highlight his dedication to improving healthcare. His work at the University of California exemplifies the impact that inventors can have on medical advancements.